Question 1
What is an advantage of cohort designs?
Correct Answer:
Establish temporality; calculate risk; versatile design; good with institutional records
Explanation:
Cohort designs shine because you can establish temporality, calculate risk, enjoy versatility, and make good use of institutional records. Following exposures over time lets you see that the exposure happened before the outcome, which strengthens the inference that the exposure could be related to the outcome. This temporal sequence is much clearer in cohort studies than in designs where data are collected at a single point in time. You can also compute risk directly since you’re tracking incident cases as they occur, allowing you to derive incidence rates and relative risks or risk differences. This quantitative view of how often outcomes arise in exposed versus unexposed groups is a core strength of cohort research. The design is versatile because it supports studying multiple outcomes from a single exposure, comparing different levels of exposure, and choosing prospective or retrospective approaches depending on data availability. This flexibility makes cohort studies applicable to a wide range of questions and settings. Using institutional records, such as electronic health records or registries, is another advantage. Cohorts can be built from existing data sources, reducing the burden of new data collection and often improving data completeness for exposure and outcome ascertainment when records are reliable. Other options don’t fit as well: rare diseases are typically studied more efficiently with case-control designs; quick and inexpensive investigations are more characteristic of cross-sectional or case-control studies; and no observational design provides instant causal proof with no bias, since all such studies are subject to biases like confounding and misclassification.
Question 2
Which statement correctly defines incidence rate?
Correct Answer:
Incidence rate is the number of new cases per person-time at risk.
Explanation:
Incidence rate is about measuring how fast new cases appear in a population, taking into account both how many people are followed and for how long they are followed. It is calculated as the number of new cases divided by the total time that people were at risk, so the units are typically cases per person-time (for example, cases per 1,000 person-years). This differs from simply the probability of developing the outcome over a fixed period, which is called risk or cumulative incidence and does not account for varying follow-up times. It’s also not the total number of existing cases in the population (prevalence), and it’s not a measure of association like relative risk, which compares incidence between groups. So the statement that defines incidence rate as the number of new cases per person-time at risk is the correct one.
Question 3
What does a significant log-rank test indicate when comparing survival curves?
Correct Answer:
It indicates a difference in survival over time but not the size of the difference
Explanation:
The log-rank test is used to compare how survival experiences differ across groups over the entire follow-up period. When the result is statistically significant, it means there is evidence that the survival curves are not the same over time—the groups have different survival experiences at some points during follow-up. But the test does not quantify how large that difference is at any time point or overall; it only tells you that a difference exists. To gauge the size or direction of the difference, you’d look at effect measures from other analyses (like hazard ratios from a Cox model) or examine time-specific differences. It also doesn’t imply causation, and a non-significant result doesn’t prove identical survival—just that there isn’t strong evidence of a difference given the data.
Question 4
In a two-by-two table, which cell corresponds to Exposed and Disease?
Correct Answer:
Exposed+Disease
Explanation:
In a two-by-two table, one axis shows exposure status (exposed vs not exposed) and the other shows disease status (disease vs no disease). The cell that represents people who are both exposed and have the disease is the intersection where Exposed and Disease meet. That’s why this cell is described as Exposed+Disease—the group that has both attributes. This cell is the key for understanding how exposure relates to disease and for calculating measures like incidence in the exposed group or the odds ratio. The other cells correspond to exposed without disease, not exposed with disease, and not exposed without disease.
Question 5
Which method assesses unmeasured confounding that could explain away an observed association?
Correct Answer:
E-value
Explanation:
The method being tested is a sensitivity measure that tells you how strong an unmeasured confounder would have to be to explain away the observed association. The E-value does this by providing the minimum strength of association that an unknown confounder would need to have with both the exposure and the outcome to nullify the observed effect, under the usual study assumptions. It helps you gauge the robustness of findings in observational studies without having measured that confounder. This is not what a Kaplan-Meier curve does—that curve shows survival probabilities over time and doesn’t quantify how much unmeasured confounding could bias results. It’s also not the hazard ratio, which is a measure of effect size between groups but doesn’t itself assess potential unmeasured confounding. And a Mann-Whitney test compares distributions between groups without addressing confounding at all. So the E-value is the tool that explicitly addresses how unmeasured confounding could influence the observed association. For intuition, if you observe a risk ratio of, say, 2.0, the E-value would be 2.0 + sqrt(2.0*(2.0-1)) ≈ 3.41. That means an unmeasured confounder would need to have a fairly strong association (risk ratio around 3.4) with both the exposure and the outcome to fully explain away the observed association. The larger the E-value, the more robust the finding is to potential unmeasured confounding.
Question 1
Exam overview

About this Exam

Prepare with the Cohort Studies Practice Test practice quiz. This question bank includes 10 questions covering cohort, incidence, population, bias, and helps. Use it to review important concepts, identify knowledge gaps, and build confidence for the related exam, course, or assessment.

More details

Additional Information

Cohort Studies Practice Test

This practice set contains 10 questions from the matching question bank and focuses on cohort, incidence, population, bias, and helps. Work through each question carefully, review the provided solutions, and revisit topics that need more study before your next attempt.

This is an independent study resource intended for practice and review; it is not an official examination or an endorsement by any organization named in the title.

Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions